Ishiguro H - Search Results

1

A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy.

Leen AJ, Yap DWT, Teo CB, Tan BKJ, Molassiotis A, Ishiguro H, Fan SWX, Sundar R, Soon YY, Bandla A. Leen AJ, et al. Among authors: ishiguro h. Front Oncol. 2022 Jan 5;11:763229. doi: 10.3389/fonc.2021.763229. eCollection 2021. Front Oncol. 2022. PMID: 35070969 Free PMC article.

2

Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study.

Kinoshita T, Nakayama T, Fukuma E, Inokuchi M, Ishiguro H, Ogo E, Kikuchi M, Jinno H, Yamazaki N, Toi M. Kinoshita T, et al. Among authors: ishiguro h. Front Oncol. 2019 Aug 6;9:733. doi: 10.3389/fonc.2019.00733. eCollection 2019. Front Oncol. 2019. PMID: 31448235 Free PMC article.

3

Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial.

Hanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, Imai S, Hamabe Y, Toi M, Arai H, Tsuboyama T. Hanai A, et al. Among authors: ishiguro h. J Natl Cancer Inst. 2018 Feb 1;110(2):141-148. doi: 10.1093/jnci/djx178. J Natl Cancer Inst. 2018. PMID: 29924336 Free PMC article.

4

Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX.

Mori Y, Nishimura T, Kitano T, Yoshimura K, Matsumoto S, Kanai M, Hazama M, Ishiguro H, Nagayama S, Yanagihara K, Teramukai S, Chiba T, Sakai Y, Fukushima M. Mori Y, et al. Among authors: ishiguro h. Oncology. 2010;79(1-2):136-43. doi: 10.1159/000320613. Epub 2010 Dec 8. Oncology. 2010. PMID: 21150228

5

Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature.

Kiba T, Nishimura T, Matsumoto S, Hatano E, Mori A, Yasumi S, Doi R, Ikai I, Kitano T, Nishimura T, Yoshikawa K, Ishiguro H, Yanagihara K, Doi E, Teramukai S, Fukushima M. Kiba T, et al. Among authors: ishiguro h. Oncology. 2006;70(5):358-65. doi: 10.1159/000098109. Epub 2006 Dec 15. Oncology. 2006. PMID: 17179730 Review.

6

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.

Toi M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Shimizu A, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Kinoshita T, Kai Y, Kitada M, Sato Y, Jimbo K, Sato N, Ishiguro H, Takada M, Ohashi Y, Ohno S. Toi M, et al. Among authors: ishiguro h. Lancet Oncol. 2021 Jan;22(1):74-84. doi: 10.1016/S1470-2045(20)30534-9. Lancet Oncol. 2021. PMID: 33387497 Clinical Trial.

7

The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients.

Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M. Tanaka S, et al. Among authors: ishiguro h. NPJ Precis Oncol. 2017 Apr 17;1(1):6. doi: 10.1038/s41698-017-0006-1. eCollection 2017. NPJ Precis Oncol. 2017. PMID: 29872695 Free PMC article.

8

Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients.

Ali AM, Ueno T, Tanaka S, Takada M, Ishiguro H, Abdellah AZ, Toi M. Ali AM, et al. Among authors: ishiguro h. Eur J Cancer. 2011 Oct;47(15):2265-72. doi: 10.1016/j.ejca.2011.06.015. Epub 2011 Jul 5. Eur J Cancer. 2011. PMID: 21737256 Free article.

9

Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.

Masuda N, Bando H, Yamanaka T, Kadoya T, Takahashi M, Nagai SE, Ohtani S, Aruga T, Suzuki E, Kikawa Y, Yasojima H, Kasai H, Ishiguro H, Kawabata H, Morita S, Haga H, Kataoka TR, Uozumi R, Ohno S, Toi M. Masuda N, et al. Among authors: ishiguro h. Breast Cancer Res Treat. 2021 Jul;188(1):117-131. doi: 10.1007/s10549-021-06184-w. Epub 2021 Mar 25. Breast Cancer Res Treat. 2021. PMID: 33763789 Free PMC article. Clinical Trial.

10

[A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide].

Yoshibayashi H, Ishiguro H, Takada M, Takeuchi M, Yamashiro H, Ueno T, Kato H, Yoshikawa K, Kanao S, Yamauchi C, Mikami Y, Toi M. Yoshibayashi H, et al. Among authors: ishiguro h. Gan To Kagaku Ryoho. 2008 Jun;35(6):987-90. Gan To Kagaku Ryoho. 2008. PMID: 18633230 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

924 results

Search Page

Filters